Samuel (Sandy) Aronson, ALM, MA, executive director of IT and AI Solutions for Mass General Brigham Personalized Medicine and senior director of IT and AI Solutions for the Accelerator for Clinical Transformation, is the corresponding author of a paper published in NEJM AI that looked at whether generative AI could hold promise for improving scientific literature review of variants in clinical genetic testing.
Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industry
Poison centers reported a sharp increase in calls related to accidental overdoses of the diabetes and weight-loss drug semaglutide (Ozempic, Wegovy). (CNN) Some patients with
December 20, 2023